Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease

This publication has 11 references indexed in Scilit:

• Phase 1/2 Placebo-Controlled, Double-Blind, Dose-Escalating Trial of Myocardial Vascular Endothelial Growth Factor 2 Gene Transfer by Catheter Delivery in Patients With Chronic Myocardial Ischemia
  Circulation, 2002
• Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina Pectoris
  Circulation, 2002
• Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2
  Circulation, 2002
• Standardized Myocardial Segmentation and Nomenclature for Tomographic Imaging of the Heart
  Circulation, 2002
• Implantation of Bone Marrow Mononuclear Cells Into Ischemic Myocardium Enhances Collateral Perfusion and Regional Function via Side Supply of Angioblasts, Angiogenic Ligands, and Cytokines
  Circulation, 2001
• Transendocardial delivery of autologous bone marrow enhances collateral perfusion and regional function in pigs with chronic experimental myocardial ischemia
  Journal of the American College of Cardiology, 2001
• Local Implantation of Autologous Bone Marrow Cells for Therapeutic Angiogenesis in Patients With Ischemic Heart Disease. Clinical Trial and Preliminary Results.
  Japanese Circulation Journal, 2001
• Electromagnetic guidance for catheter-based transendocardial injection: a platform for intramyocardial angiogenesis therapy
  Journal of the American College of Cardiology, 2000
• Effect of Intracoronary Recombinant Human Vascular Endothelial Growth Factor on Myocardial Perfusion
  Circulation, 2000
• Development and evaluation of the Seattle Angina questionnaire: A new functional status measure for coronary artery disease
  Journal of the American College of Cardiology, 1995